<SEC-DOCUMENT>0001558370-24-008208.txt : 20240515
<SEC-HEADER>0001558370-24-008208.hdr.sgml : 20240515
<ACCEPTANCE-DATETIME>20240515071455
ACCESSION NUMBER:		0001558370-24-008208
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20240514
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240515
DATE AS OF CHANGE:		20240515

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Adaptimmune Therapeutics PLC
		CENTRAL INDEX KEY:			0001621227
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			X0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37368
		FILM NUMBER:		24947129

	BUSINESS ADDRESS:	
		STREET 1:		60 JUBILEE AVENUE
		STREET 2:		MILTON PARK
		CITY:			ABINGDON, OXFORDSHIRE
		STATE:			X0
		ZIP:			OX14 4RX
		BUSINESS PHONE:		44 1235 430000

	MAIL ADDRESS:	
		STREET 1:		60 JUBILEE AVENUE
		STREET 2:		MILTON PARK
		CITY:			ABINGDON, OXFORDSHIRE
		STATE:			X0
		ZIP:			OX14 4RX

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Adaptimmune Ltd
		DATE OF NAME CHANGE:	20141001
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>adap-20240514x8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- iXBRL document created with: Toppan Merrill Bridge iXBRL 10.6.2.5 -->
<!-- Based on: iXBRL 1.1 -->
<!-- Created on: 5/13/2024 6:03:59 PM -->
<!-- iXBRL Library version: 1.0.8826.24652 -->
<!-- iXBRL Service Job ID: 279ad969-f11c-4d72-93b8-ccf0914638cd -->
<html xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns="http://www.w3.org/1999/xhtml" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:adap="http://www.adaptimmune.com/20240514" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrli="http://www.xbrl.org/2003/instance"><head><meta http-equiv="content-type" content="text/html"/><title></title></head><body><div style="margin-top:30pt;"></div><div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric contextRef="Duration_5_14_2024_To_5_14_2024_0KCULC8OSkCsdxvrliLgvw" name="dei:EntityCentralIndexKey" id="Tc_UrMgHWF7dEiBJCRz71v1Yg_2_1">0001621227</ix:nonNumeric><ix:nonNumeric contextRef="Duration_5_14_2024_To_5_14_2024_0KCULC8OSkCsdxvrliLgvw" name="dei:AmendmentFlag" id="Tc_s-VMlvcn-EycMYk3kB_9pA_3_1">false</ix:nonNumeric><ix:nonNumeric contextRef="Duration_5_14_2024_To_5_14_2024_0KCULC8OSkCsdxvrliLgvw" name="dei:EntityTaxIdentificationNumber" id="Hidden_EKI0DcY0HES7XHCvhSvvtw">00-0000000</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="adap-20240514.xsd" xlink:type="simple"/></ix:references><ix:resources><xbrli:context id="Duration_5_14_2024_To_5_14_2024_0KCULC8OSkCsdxvrliLgvw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001621227</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-05-14</xbrli:startDate><xbrli:endDate>2024-05-14</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:1pt;padding-top:1pt;border-bottom:1.0pt solid #000000;border-top:3.0pt solid #000000;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_7496f995_a2ab_489f_8c05_ca9df3b19c92"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:18pt;font-weight:bold;">UNITED STATES </b><b style="font-size:18pt;font-weight:bold;"><br/></b><b style="font-size:18pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Washington, D.C. 20549</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:18pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">FORM&#160;</b><ix:nonNumeric contextRef="Duration_5_14_2024_To_5_14_2024_0KCULC8OSkCsdxvrliLgvw" name="dei:DocumentType" id="Narr_QdeSxPRds0-og9j83FRK1Q"><b style="font-weight:bold;">8-K</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:12pt;font-weight:bold;">Current Report</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:12pt;font-weight:bold;">Pursuant to Section&#160;13 or 15(d)&#160;of</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:12pt;font-weight:bold;">the Securities Exchange Act of 1934</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">Date of Report (Date of earliest event reported):<b style="font-weight:bold;"> </b><ix:nonNumeric contextRef="Duration_5_14_2024_To_5_14_2024_0KCULC8OSkCsdxvrliLgvw" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="Narr_vRCwpj02oUiTj8h1tY8D_Q"><b style="font-weight:bold;">May 14, 2024</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:18pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_5_14_2024_To_5_14_2024_0KCULC8OSkCsdxvrliLgvw" name="dei:EntityRegistrantName" id="Narr_SqtrH2LwU0eaYSr-TDJgow"><b style="font-weight:bold;">ADAPTIMMUNE THERAPEUTICS PLC</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">(Exact name of registrant as specified in its charter)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_a955ef0e_e52b_4858_9ce4_6782eccbb535"></a><a id="Tc_hgNLg408b0SkDF9zWGbNLg_2_0"></a><a id="Tc_xsp-LbKuZEyI4u5Q5nsH5Q_2_2"></a><a id="Tc_WAFfosTQUUmYxxz2COfJag_2_4"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:top;width:32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_5_14_2024_To_5_14_2024_0KCULC8OSkCsdxvrliLgvw" format="ixt-sec:edgarprovcountryen" name="dei:EntityIncorporationStateCountryCode" id="Tc_cjnQgqgmKkyNbI7EkLS63g_1_0"><b style="font-weight:bold;">England and Wales</b></ix:nonNumeric></p></td><td style="vertical-align:bottom;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_5_14_2024_To_5_14_2024_0KCULC8OSkCsdxvrliLgvw" name="dei:EntityFileNumber" id="Tc_im9xCY5cokuv6CyIwq0JCQ_1_2"><b style="font-weight:bold;">1-37368</b></ix:nonNumeric></p></td><td style="vertical-align:bottom;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="-sec-ix-hidden:Hidden_EKI0DcY0HES7XHCvhSvvtw;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Not Applicable</b></span></p></td></tr><tr><td style="vertical-align:top;width:32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">(State or other jurisdiction of<br/>incorporation)</p></td><td style="vertical-align:bottom;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">(Commission File Number)</p></td><td style="vertical-align:bottom;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">(IRS Employer Identification No.)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_5_14_2024_To_5_14_2024_0KCULC8OSkCsdxvrliLgvw" name="dei:EntityAddressAddressLine1" id="Narr_KBMlrHInF06YUN9Ricl6DA"><b style="font-weight:bold;">60 Jubilee Avenue</b></ix:nonNumeric><b style="font-weight:bold;">, </b><ix:nonNumeric contextRef="Duration_5_14_2024_To_5_14_2024_0KCULC8OSkCsdxvrliLgvw" name="dei:EntityAddressAddressLine2" id="Narr_kUodsGQwnEOhX8gF8LUQ9w"><b style="font-weight:bold;">Milton Park</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_5_14_2024_To_5_14_2024_0KCULC8OSkCsdxvrliLgvw" name="dei:EntityAddressCityOrTown" id="Narr_UQcv0B1KMkS3HhQDcfmAJQ"><b style="font-weight:bold;">Abingdon, Oxfordshire</b></ix:nonNumeric><b style="font-weight:bold;"> </b><ix:nonNumeric contextRef="Duration_5_14_2024_To_5_14_2024_0KCULC8OSkCsdxvrliLgvw" name="dei:EntityAddressPostalZipCode" id="Narr_v5_txZ0MkU2VsIPxnVHNMQ"><b style="font-weight:bold;">OX14 4RX</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_5_14_2024_To_5_14_2024_0KCULC8OSkCsdxvrliLgvw" format="ixt-sec:countrynameen" name="dei:EntityAddressCountry" id="Narr_K0v1cooHmkum9pUjrLMS0g"><b style="font-weight:bold;">United Kingdom</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">(Address of principal executive offices, including zip code)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(</b><ix:nonNumeric contextRef="Duration_5_14_2024_To_5_14_2024_0KCULC8OSkCsdxvrliLgvw" name="dei:CityAreaCode" id="Narr_XqB9XwCDP0yEaSbv1u3c-A"><b style="font-weight:bold;">44</b></ix:nonNumeric><b style="font-weight:bold;">) </b><ix:nonNumeric contextRef="Duration_5_14_2024_To_5_14_2024_0KCULC8OSkCsdxvrliLgvw" name="dei:LocalPhoneNumber" id="Narr_wNw4WR8VSEGVk0kQoawW3g"><b style="font-weight:bold;">1235 430000</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">(Registrant&#8217;s telephone number, including area code)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Check the appropriate box below if the Form&#160;8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 25.9pt;"><span style="display:inline-block;text-indent:0pt;width:23.1pt;"><ix:nonNumeric contextRef="Duration_5_14_2024_To_5_14_2024_0KCULC8OSkCsdxvrliLgvw" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="Narr_c77Z3AvnMkCHt4LK3q--cw"><span style="font-family:'Segoe UI Symbol';font-size:10pt;font-style:normal;font-weight:normal;">&#9744;</span></ix:nonNumeric></span>Written communications pursuant to Rule&#160;425 under the Securities Act (17 CFR 230.425)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 25.9pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 25.9pt;"><span style="display:inline-block;text-indent:0pt;width:23.1pt;"><ix:nonNumeric contextRef="Duration_5_14_2024_To_5_14_2024_0KCULC8OSkCsdxvrliLgvw" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="Narr_2V5K3gQyQUO6V_SJI7FaXA"><span style="font-family:'Segoe UI Symbol';font-size:10pt;font-style:normal;font-weight:normal;">&#9744;</span></ix:nonNumeric></span>Soliciting material pursuant to Rule&#160;14a-12 under the Exchange Act (17 CFR 240.14a-12)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 25.9pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 25.9pt;"><span style="display:inline-block;text-indent:0pt;width:23.1pt;"><ix:nonNumeric contextRef="Duration_5_14_2024_To_5_14_2024_0KCULC8OSkCsdxvrliLgvw" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="Narr_v7GPUAcuQUmLqlVGI6VmTQ"><span style="font-family:'Segoe UI Symbol';font-size:10pt;font-style:normal;font-weight:normal;">&#9744;</span></ix:nonNumeric></span>Pre-commencement communications pursuant to Rule&#160;14d-2(b)&#160;under the Exchange Act (17 CFR 240.14d-2(b))</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 25.9pt;"><span style="margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 25.9pt;"><span style="display:inline-block;text-indent:0pt;width:23.1pt;"><ix:nonNumeric contextRef="Duration_5_14_2024_To_5_14_2024_0KCULC8OSkCsdxvrliLgvw" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="Narr_FA1vISvpMkmIDTLV1Ea_zw"><span style="font-family:'Segoe UI Symbol';font-size:10pt;font-style:normal;font-weight:normal;">&#9744;</span></ix:nonNumeric></span>Pre-commencement communications pursuant to Rule&#160;13e-4(c)&#160;under the Exchange Act (17 CFR 240.13e-4(c))</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Securities registered pursuant to Section&#160;12(b)&#160;of the Act:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_602dac61_edc2_4936_8590_9ecf753fb00c"></a><a id="Tc_MFdm2WgvxEiORt0RPvdbXA_0_0"></a><a id="Tc_82TbmD4rQ0enRVQHVLZVMA_0_2"></a><a id="Tc_UC3LM4I5UEeg32Xv64m7zw_0_4"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr><td style="vertical-align:bottom;width:32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Title&#160;of&#160;each&#160;class</b></p></td><td style="vertical-align:bottom;width:2%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Trading&#160;Symbol</b></p></td><td style="vertical-align:bottom;width:2%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Name&#160;of&#160;each&#160;exchange&#160;on&#160;which</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">registered</b></p></td></tr><tr><td style="vertical-align:top;width:32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_5_14_2024_To_5_14_2024_0KCULC8OSkCsdxvrliLgvw" name="dei:Security12bTitle" id="Tc_7RIWzbn42UCEfXHd20BVdg_1_0">American Depositary Shares, each representing 6 Ordinary Shares, par value &#163;0.001 per share</ix:nonNumeric></p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_5_14_2024_To_5_14_2024_0KCULC8OSkCsdxvrliLgvw" name="dei:TradingSymbol" id="Tc_laFnw_-ccEWGjyuznqrdUA_1_2">ADAP</ix:nonNumeric></p></td><td style="vertical-align:top;width:2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_5_14_2024_To_5_14_2024_0KCULC8OSkCsdxvrliLgvw" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="Tc_n_80PjYbV0mrjdtVQaviyQ_1_4">The Nasdaq Global Select Market</ix:nonNumeric></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule&#160;405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule&#160;12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 18pt 0pt 0pt;">Emerging growth company <ix:nonNumeric contextRef="Duration_5_14_2024_To_5_14_2024_0KCULC8OSkCsdxvrliLgvw" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="Narr_Y5E6Hiuxuk21c0soopIzSA"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a)&#160;of the Exchange Act.<span style="font-family:'Segoe UI Symbol';">&#9744;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:1pt;padding-top:1pt;border-bottom:3.0pt solid #000000;border-top:1.0pt solid #000000;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><a id="_067fba00_e8e9_4345_b46d_0fe0fabbbdb3"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;">Item 1.01   Entry into a Material Definitive Agreement.</b></p><a id="_Hlk166411538"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:14pt 0pt 0pt 0pt;">On May 14, 2024 (the &#8220;Closing Date&#8221;), Adaptimmune Therapeutics plc (the &#8220;Company&#8221; and collectively with any Company affiliates that are made party to the Loan Agreement, &#8220;Borrower&#8221;) entered into a Loan and Security Agreement (the &#8220;Loan Agreement&#8221;), with several banks and other financial institutions or entities from time to time party hereto as lenders (each, a &#8220;Lender&#8221;, and collectively &#8220;Lenders&#8221;) and Hercules Capital, Inc., a Maryland corporation in its capacity as administrative agent and collateral agent for itself and the Lenders (in such capacity, including any successors or assigns, the &#8220;Agent&#8221;), for a term loan facility of up to $125.0 million (the &#8220;Term Loan&#8221;), consisting of a term loan advance in the aggregate principal amount equal to $25.0 million on the Closing Date (the &#8220;Tranche 1 Advance&#8221;), a term loan advance available to the Company subject to certain terms and conditions in the aggregate principal amount of $25.0 million (the &#8220;Tranche 2 Advance&#8217;), a term loan advance available subject to certain terms and conditions in the aggregate amount of $5.0 million (the &#8220;Tranche 3 Advance&#8221;), a term loan advance available subject to certain terms and conditions in the aggregate principal amount of $30.0 million (the &#8220;Tranche 4 Advance&#8221;) and a term loan advance available in the sole discretion of the Lenders and subject to certain terms and conditions in the aggregate principal amount of $40.0 million (the &#8220;Tranche 5 Advance&#8221; and together with each Tranche Advance, the &#8220;Term Loan Advances&#8221;). The proceeds of the Term Loan will be used solely to repay related fees and expenses in connection with the Loan Agreement and for working capital and general corporate purposes. </p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:justify;margin:12pt 0pt 0pt 0pt;"><span style="font-size:10pt;">The Tranche 2 Advance will be available, subject to customary terms and conditions, during the period commencing on the date that Borrower shall have received U.S. Food and Drug Administration (&#8220;FDA&#8221;) approval for the sale and marketing of </span><span style="font-size:10pt;"> </span><span style="font-size:10pt;">afami-cel for the treatment of advanced synovial sarcoma and continuing through the earlier of (a) June 30, 2025, and (b) the date that is thirty (30) days after the first date on which Borrower shall have received FDA approval for the sale and marketing of</span> <span style="font-size:10pt;">afami-cel for the treatment of advanced synovial sarcoma. The Tranche 3 Advance, Tranche 4 Advance and Tranche 5 Advance will be available, subject to customary terms and conditions, on the Company meeting certain performance conditions relating to its afami-cel and lete-cel products..</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:12pt 0pt 0pt 0pt;">The Term Loan will mature on June 1, 2029 (the &#8220;Maturity Date&#8221;). Borrowings under the Loan Agreement bear interest at an annual rate equal to the greater of (i) 9.65% or (ii) 1.15% plus the Wall Street Journal prime rate. Accrued interest on the Term Loan is payable monthly in arrears. Additionally, the principal balance of each Term Loan Advance shall bear interest from the date advanced to one year from the date thereof, in an amount equal to 2.0%, which shall be added to the outstanding principal balance so as to increase the outstanding principal balance. There will be a tranche facility charge on any Term Loan Advance, except for the Tranche 1 Advance or Tranche 2 Advance, of 1.0% of such advance. Upon the occurrence and continuance of an event of default, a default interest rate of an additional 4.0% may be applied to any outstanding secured obligations, and the Agent may declare all outstanding obligations immediately due and payable and take such other actions as set forth in the Loan Agreement.</p><a id="_Hlk166411396"></a><a id="_Hlk166408892"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:12pt 0pt 0pt 0pt;">At the Borrower&#8217;s option, the Borrower may prepay all or any portion greater than $5.0 million (and increments of $1.0 million) of the outstanding borrowings, subject to a prepayment premium equal to (i) 3.0% of the principal amount outstanding if the prepayment occurs during the first year following the Closing Date, (ii) 2.0% of the principal amount outstanding if the prepayment occurs during the second year following the Closing Date, and (iii) 1.0% of the principal amount outstanding if the prepayment occurs thereafter but prior to the Maturity Date. In addition, the Borrowers paid a $500,000 facility charge upon closing. The Loan Agreement also provides for an end of term charge, payable upon maturity or the repayment of obligations under the agreement, equal to 5.85% of the principal amount of the Term Loan (if fully prepaid), or 5.85% of the principal amount being prepaid, if Borrower partially prepays the Term Loan.</p><a id="_Hlk166411522"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:12pt 0pt 0pt 0pt;">The Term Loan is secured by a lien on substantially all of Borrower&#8217;s existing or after-acquired assets, including intellectual property, subject to customary exceptions. In addition, the Loan Agreement contains customary closing and commitment fees, prepayment fees and provisions, events of default and representations, warranties and affirmative and negative covenants, including a financial covenant requiring the Company to maintain certain levels of cash in accounts subject to a control agreement in favor of the Agent (the &#8220;Qualified Cash&#8221;) during the period commencing on January 1, 2025 (which initial commencement date is subject to adjustment if certain performance milestones are met) and at all times thereafter, provided that if the Company has achieved certain performance milestones, the amount of Qualified Cash is subject to certain reductions. The Loan Agreement also includes customary events of default, including payment defaults, breaches of covenants following any applicable cure period, the occurrence of certain events that could reasonably be expected to have a &#8220;material adverse effect&#8221; as set forth in the Loan Agreement, cross acceleration to third-party indebtedness and certain events relating to bankruptcy or insolvency. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:12pt 0pt 0pt 0pt;"><span style="background:#ffffff;">The foregoing description of the Loan Agreement is only a summary of the material terms thereof, and does not purport to be complete. The description is qualified in its entirety by reference to the complete text of the Loan Agreement to be filed with the Securities and Exchange Commission in connection with the Company&#8217;s Form 10-Q for the quarter ended June 30, 2024.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.79;margin:14pt 0pt 0pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:72pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Item 2.03</b></span><b style="font-weight:bold;">Creation of a Direct Financial Obligation or an Obligation Under an Off-Balance Sheet Arrangement of a Registrant.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:14pt 0pt 0pt 0pt;">The information set forth above and referenced under Item 1.01 regarding the Loan Agreement is hereby incorporated by reference into this Item 2.03.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.79;margin:14pt 0pt 0pt 0pt;"><span style="display:inline-block;text-indent:0pt;width:72pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Item 7.01</b></span><b style="font-weight:bold;white-space:pre-wrap;">Regulation FD Disclosure.  </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:14pt 0pt 0pt 0pt;">On May 15, 2024, the Company issued a press release announcing the Loan Agreement described above. A copy of the press release is being filed as Exhibit 99.1 to this current report on Form 8-K and is incorporated herein by reference.&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:12pt 0pt 0pt 0pt;">The information contained under Item 7.01 of this Current Report on Form 8-K (including Exhibit 99.1), shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act except as may be expressly set forth by specific reference in such filing.</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Item 9.01&#160;&#160;&#160;&#160;Financial Statements and Exhibits.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 36pt;">(d)&#160; Exhibits.</p><div style="padding-left:36pt;"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:86%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:12.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:2.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:12.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.37;margin:0pt;"><b style="font-weight:bold;">Exhibit&#160;No.</b></p></td><td style="vertical-align:bottom;width:2.49%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.37;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.37;text-align:center;margin:0pt;"><b style="font-weight:bold;">Description&#160;of&#160;Exhibit</b></p></td></tr><tr><td style="vertical-align:top;width:12.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.37;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:2.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.37;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.37;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:12.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.37;text-align:center;margin:0pt;">99.1</p></td><td style="vertical-align:bottom;width:2.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.37;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.37;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="adap-20240514xex99d1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Press release dated May 15, 2024</span></a></p></td></tr><tr><td style="vertical-align:top;width:12.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.37;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:2.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.37;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.37;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:12.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.37;text-align:center;margin:0pt;">104</p></td><td style="vertical-align:bottom;width:2.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.37;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.37;margin:0pt;">Cover Page Interactive Date File (embedded within the Inline XBRL document)</p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:100%;background:#ffffff;"><tr style="height:1pt;"><td style="vertical-align:top;white-space:nowrap;width:3.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:middle;width:96.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"></div></div></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">SIGNATURES</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:50.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:4.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:40%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td></tr><tr><td style="vertical-align:top;width:50.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:top;width:49.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">ADAPTIMMUNE THERAPEUTICS PLC</p></td></tr><tr><td style="vertical-align:top;width:50.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:4.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:top;width:45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:50.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Date: May 15, 2024</p></td><td style="vertical-align:top;width:4.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">By:</p></td><td colspan="2" style="vertical-align:top;width:45%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">/s/ Margaret Henry</p></td></tr><tr><td style="vertical-align:top;width:50.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:4.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Name:</p></td><td style="vertical-align:top;width:40%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Margaret Henry</p></td></tr><tr><td style="vertical-align:top;width:50.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:4.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Title:</p></td><td style="vertical-align:top;width:40%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Corporate Secretary</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:avoid;width:88.24%;border:0;"></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>adap-20240514xex99d1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  10.6.125.0--><!--Created on: 5/13/2024 06:03:58 PM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:right;margin:0pt 0pt 8pt 0pt;"><b style="font-weight:bold;">Exhibit 99.1</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:right;margin:0pt;"><font style="color:#ffffff;"><img src="adap-20240514xex99d1001.jpg" alt="Graphic" style="display:inline-block;height:23.94pt;width:149.62pt;"></font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:right;margin:0pt 0pt 8pt 0pt;"><font style="font-size:10pt;font-weight:bold;line-height:1.28;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt 0pt 8pt 0pt;"><b style="font-size:12pt;font-weight:bold;">Adaptimmune Secures up to $125 Million Debt Financing with Hercules Capital</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt 0pt 8pt 0pt;"><font style="font-size:12pt;">First tranche of $25 million available upon closing; the Company will be eligible to draw an additional $25 million subject to afami-cel approval</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.27;margin:0pt 0pt 8pt 0pt;"><font style="font-size:12pt;">PHILADELPHIA, PA. and OXFORD, UK, May 15</font><font style="font-size:12pt;background:#ffffff;">, 2024 &#8211; Adaptimmune Therapeutics plc&#160;(Nasdaq: ADAP), a company redefining the treatment of solid tumor cancers with cell therapy, today announced that it has entered into a $125 million five-year, term loan facility with Hercules Capital, Inc. (NYSE: HTGC) (&#8220;Hercules&#8221;). The transaction strengthens the Company&#8217;s balance sheet as it executes on its sarcoma franchise with the commercial launch of afami-cel later this year and lete-cel planned for 2026. The Company will host a live webcast at 8:00 a.m. EDT (1:00&#160;p.m. BST) today to report its Q1 financial and business updates.</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 8pt 0pt;"><b style="font-size:12pt;font-weight:bold;">Gavin Wood, Adaptimmune&#8217;s Chief Financial Officer:</b><font style="font-size:12pt;"> &#8220;We are focused on getting products to market starting with afami-cel later this year. We know that afami-cel has the potential to make a tremendous difference for people with sarcoma and we are pleased to partner with Hercules Capital in this transaction to strengthen our balance sheet.&#8221;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 8pt 0pt;"><b style="font-size:12pt;font-weight:bold;">R. Bryan Jadot - Senior Managing Director and Group Head at Hercules Capital:</b><font style="font-size:12pt;"> &#8220;Hercules is excited to partner with Adaptimmune as they prepare to launch afami-cel and bring this therapy to patients living with synovial sarcoma. We are proud to support Adaptimmune&#8217;s mission to design and deliver cell therapies to transform the lives of people with cancer.&#8221;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 8pt 0pt;"><b style="font-size:12pt;font-weight:bold;">Jeffrey Ralto &#8211; Principal at Hercules Capital: &#8220;</b><font style="font-size:12pt;white-space:pre-wrap;">We are proud to support Adaptimmune mission of developing and commercializing treatments for people with cancer.  This financing should help support Adaptimmune&#8217;s clinical and commercial strategies.&#8221;</font><b style="font-size:12pt;font-weight:bold;white-space:pre-wrap;">   </b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 8pt 0pt;"><font style="font-size:12pt;">The term loan facility provides for up to $125 million of term loans in aggregate, available in up to five tranches. Upon closing of the transaction, the first tranche of $25 million can be drawn. Under the terms of the agreement, Adaptimmune will be eligible to draw an additional tranche of $25&#160;million upon afami-cel approval, and three additional tranches totaling $75 million over the medium-term subject to certain conditions.</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 8pt 0pt;"><font style="font-size:12pt;">Additional details of the loan agreement will be filed with the Securities and Exchange Commission on a Current Report on Form 8-K.</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;padding-bottom:8pt;margin:0pt;"><font style="font-size:12pt;">TD Cowen acted as sole financial advisor to the Company. Ropes &amp; Gray served as legal counsel to Adaptimmune and DLA Piper served as legal counsel to Hercules.</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;background:#ffffff;margin:0pt;"><b style="font-size:12pt;font-weight:bold;">Today&#8217;s Webcast Details for Adaptimmune&#8217;s Q1 financial and business updates</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;padding-bottom:15pt;background:#ffffff;margin:0pt;"><font style="font-size:12pt;">A live webcast and replay can be accessed at </font><u style="color:#0000ff;font-size:12pt;text-decoration-line:underline;text-decoration-style:solid;">https://www.gowebcasting.com/13334</u><font style="font-size:12pt;">. </font><font style="font-size:12pt;">Call in information is as follows: </font><b style="font-size:12pt;font-weight:bold;">1-800-806-5484 </b><font style="font-size:12pt;">(US or Canada) or </font><b style="font-size:12pt;font-weight:bold;">+416-340-2217 </b><font style="font-size:12pt;">(International and additional options available </font><u style="color:#0000ff;font-size:12pt;text-decoration-line:underline;text-decoration-style:solid;">HERE</u><font style="font-size:12pt;">) and the passcode is </font><b style="font-size:12pt;font-weight:bold;">3025919#</b><font style="font-size:12pt;">. Callers should dial in 5-10&#160;minutes prior to the scheduled start time and simply ask to join the Adaptimmune call.</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;padding-bottom:15pt;background:#ffffff;margin:0pt;"><b style="font-size:12pt;font-weight:bold;">About Adaptimmune</b><font style="font-size:12pt;"><br></font><font style="font-size:12pt;">Adaptimmune is a clinical-stage biopharmaceutical company focused on designing, developing, and delivering cell therapies to transform the lives of people with cancer. The Company&#39;s unique engineered T-cell receptor (TCR) platform enables the engineering of T-cells to target and destroy cancers across multiple solid tumor types.</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;padding-bottom:15pt;background:#ffffff;margin:0pt;"><b style="font-size:12pt;font-weight:bold;">Forward-Looking Statements</b><font style="font-size:12pt;"><br></font><font style="font-size:12pt;">This release contains &quot;forward-looking statements&quot; within the meaning of the Private Securities Litigation Reform Act of 1995 (PSLRA). These forward-looking statements involve certain risks and uncertainties. Such risks and uncertainties could cause our actual results to differ materially from those indicated by such forward-looking statements, and include, without limitation: the success, cost and timing of our product development activities and clinical trials and our ability to successfully advance our TCR therapeutic candidates through the regulatory and commercialization processes. For a further description of the risks and uncertainties that could cause our actual results to differ materially from those expressed in these forward-looking statements, as well as risks relating to our business in general, we refer you to our Annual Report on Form 10-K filed with the Securities and Exchange Commission for the year ended 31&#8239;December, 2023, our Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and other filings with the Securities and Exchange Commission. The forward-looking statements contained in this press release speak only as of the date the statements were made and we do not undertake any obligation to update such forward-looking statements to reflect subsequent events or circumstances.&#160;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;background:#ffffff;margin:0pt;"><b style="font-size:12pt;font-weight:bold;">Adaptimmune Contact</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;padding-bottom:15pt;background:#ffffff;margin:0pt;"><b style="font-size:12pt;font-weight:bold;">Investor Relations</b><font style="font-size:12pt;"><br></font><font style="font-size:12pt;">Juli P. Miller, Ph.D. - VP, Corporate Affairs and Investor Relations</font><font style="font-size:12pt;"><br></font><font style="font-size:12pt;">T : +1 215 825 9310</font><font style="font-size:12pt;"><br></font><font style="font-size:12pt;">M : +1 215 460 8920</font><font style="font-size:12pt;"><br></font><u style="color:#0033cc;font-size:12pt;text-decoration-line:underline;text-decoration-style:solid;">Juli.Miller@adaptimmune.com</u></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;padding-bottom:15pt;background:#ffffff;margin:0pt;"><b style="font-size:12pt;font-weight:bold;">Media Relations</b><font style="font-size:12pt;"><br></font><font style="font-size:12pt;">Dana Lynch, Senior Director of Corporate Communications</font><font style="font-size:12pt;"><br></font><font style="font-size:12pt;">M: +1 267 990 1217</font><font style="font-size:12pt;"><br></font><u style="color:#0033cc;font-size:12pt;text-decoration-line:underline;text-decoration-style:solid;">Dana.Lynch@adaptimmune.com</u></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;background:#ffffff;margin:0pt 0pt 15pt 0pt;"><font style="color:#4a4a4a;font-size:12pt;background:#e6e6e6;"><img src="adap-20240514xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:24pt;width:150pt;"></font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:avoid;width:76.47%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>adap-20240514xex99d1001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 adap-20240514xex99d1001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  P 2P# 2(  A$! Q$!_\0
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MR2.?4FOG3Q!\(_BDG@:+PQ!X3U46TEZ]Q+N48QM&._JM?1?@;XD^*=._9O\
M$'BO7-;GNM0=2VGS.,2*PX(''J#7SKK_ ,7?BD_@:+Q/!XLU7[-'>O;R[B,$
M;1CMZM1+F]G+GV/:R?3%1Y/BZ'MOB#X4^*_#G[*UGX<\/Z1=SZU>E&NK:-0&
M57'[SO4'P.^%_B7X/?!36]2@T"Y?QA=(WV>RV+O4@X'.>XYJ?Q#\5_%?B/\
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M,>LV;B1K@QAL,,<[L5](>.XM6;PAJ-OH$:2:G-"8H2S[0"01N_"H_!O@'0O
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MU3:_X'^*_P 4]&O=/\1-9:3:F([+2V8,)F(Z,PQC\N]?2+(N!]Y\=P:B?#,
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8Z*JY#,NX_P"P33Q"6Y$K*/3%5SLCD/_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>adap-20240514xex99d1002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 adap-20240514xex99d1002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  @ ,@# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#[;^.7[0V@
M> -?3P?K,.MZ?:ZC:D2Z[IJ[#:EN!Y9(^8@<DKDKD8!/3QC0/&'B']EGQ+I5
MQ-K<GC+X3:_)OM]0#&3R]QR6'7;(,DE>CC/1L[>LCLOB5)X^N/ GQ.T-O&W@
MO7F8IJ-A9M+%IS.6V,LH0%-IX.[E1@@X'/*^!_A3XHB\$?%?X6ZSHVIW.E6:
M37^@7\UFXBDGC8[?*<C!,F$.U3WD]37T=*%"E#DDTT[7UO=/2ZZIKL<$I3<K
MGT7\;?C=HWP@^&4WBN5UOA,J+IT$;_\ 'W(XR@!_NXRQ/]T'KTKY)\-:UK&@
MWUC\</B_XRU/3)[PF31O#FEMMENXN#L\LG"PD8X/7(+-DC.58>"/'7Q4\0_!
M[P9XE\*:];>'="\P7<]]I\\<#)YK/M=F4 #RHT09_O8[UV(\ ZU\2_C]XX\;
M>-?".KWGAGPE XT?1I;&0+?^666)(E*_O VUG(&03(N>#BOD\3"4*TH+5)V7
M;U/T_*Z>%P^#7/)<TXN4GI>U[*"OLY/5OHCZB^!GQAM?C;X*3Q!:Z9>:1F9X
MFMKQ#VZ,K8 =2"#D=\CM7HYX7KBOF+]FB\^,WC#Q;>>*_&T:Z%X4FBEMK7P[
M-;FWEA8,I5UC*[L###+G)R2!C%>W?%7QW#\-O .K^()5$LUK%BW@[S3L=L2
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M 'EJ#3N?*7P- ,O[,^1GY/$G_L]>R_M/*#;_  RR,_\ %<Z7U_[:5Z?9>"]
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MNF+!<8($JK&R[U]5)4D'H1@CK7U-XA^&OA+Q9?1WVM>&M*U2]C "W%Y9I*X
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"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>adap-20240514.xsd
<DESCRIPTION>EX-101.SCH
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  10.6.2.5 -->
<!--Based on XBRL 2.1-->
<!--Created on: 5/13/2024 6:04:03 PM-->
<!--Modified on: 5/13/2024 6:04:03 PM-->
<xsd:schema xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:currency="http://xbrl.sec.gov/currency/2023" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:srt-roles="http://fasb.org/srt-roles/2023" xmlns:stpr="http://xbrl.sec.gov/stpr/2023" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:attributeFormDefault="unqualified" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:naics="http://xbrl.sec.gov/naics/2023" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:exch="http://xbrl.sec.gov/exch/2023" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:srt="http://fasb.org/srt/2023" xmlns:sic="http://xbrl.sec.gov/sic/2023" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:country="http://xbrl.sec.gov/country/2023" targetNamespace="http://www.adaptimmune.com/20240514" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:adap="http://www.adaptimmune.com/20240514" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:deprecated="http://www.xbrl.org/2009/role/deprecated" xmlns:net="http://www.xbrl.org/2009/role/net" xmlns:dtr="http://www.xbrl.org/2009/dtr" xmlns:cef="http://xbrl.sec.gov/cef/2023" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType roleURI="http://www.adaptimmune.com/role/DocumentDocumentAndEntityInformation" id="DocumentDocumentAndEntityInformation">
        <link:definition>00090 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:type="simple" xlink:href="adap-20240514_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="adap-20240514_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
  <xsd:element name="DocumentAndEntityInformationAbstract" id="adap_DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>adap-20240514_lab.xml
<DESCRIPTION>EX-101.LAB
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  10.6.2.5 -->
<!--Based on XBRL 2.1-->
<!--Created on: 5/13/2024 6:04:03 PM-->
<!--Modified on: 5/13/2024 6:04:03 PM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:href="adap-20240514.xsd#adap_DocumentAndEntityInformationAbstract" xlink:label="adap_DocumentAndEntityInformationAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="adap_DocumentAndEntityInformationAbstract" xlink:to="adap_DocumentAndEntityInformationAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="adap_DocumentAndEntityInformationAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document and Entity Information [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Type</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Period End Date</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity File Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Registrant Name</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Incorporation, State or Country Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Tax Identification Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Address Line One</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Adress Line Two</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, City or Town</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Postal Zip Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Country</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">City Area Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Local Phone Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Written Communications</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Soliciting Material</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Pre-commencement Tender Offer</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Pre-commencement Issuer Tender Offer</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Title of 12(b) Security</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trading Symbol</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Security Exchange Name</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Emerging Growth Company</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Central Index Key</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amendment Flag</label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>adap-20240514_pre.xml
<DESCRIPTION>EX-101.PRE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  10.6.2.5 -->
<!--Based on XBRL 2.1-->
<!--Created on: 5/13/2024 6:04:03 PM-->
<!--Modified on: 5/13/2024 6:04:03 PM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="adap-20240514.xsd#DocumentDocumentAndEntityInformation" roleURI="http://www.adaptimmune.com/role/DocumentDocumentAndEntityInformation" xmlns="http://www.xbrl.org/2003/linkbase" />
  <presentationLink xlink:role="http://www.adaptimmune.com/role/DocumentDocumentAndEntityInformation" xlink:type="extended" xlink:title="00090 - Document - Document and Entity Information" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="adap-20240514.xsd#adap_DocumentAndEntityInformationAbstract" xlink:label="adap_DocumentAndEntityInformationAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType_638512202435365155" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adap_DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentType_638512202435365155" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate_638512202435365155" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adap_DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentPeriodEndDate_638512202435365155" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber_638512202435365155" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adap_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityFileNumber_638512202435365155" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName_638512202435365155" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adap_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityRegistrantName_638512202435365155" order="4" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode_638512202435365155" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adap_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityIncorporationStateCountryCode_638512202435365155" order="5" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber_638512202435365155" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adap_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityTaxIdentificationNumber_638512202435365155" order="6" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1_638512202435365155" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adap_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityAddressAddressLine1_638512202435365155" order="7" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2_638512202435365155" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adap_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityAddressAddressLine2_638512202435365155" order="8" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown_638512202435365155" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adap_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityAddressCityOrTown_638512202435365155" order="9" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode_638512202435375138" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adap_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityAddressPostalZipCode_638512202435375138" order="10" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry_638512202435375138" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adap_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityAddressCountry_638512202435375138" order="11" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode_638512202435375138" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adap_DocumentAndEntityInformationAbstract" xlink:to="dei_CityAreaCode_638512202435375138" order="12" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber_638512202435375138" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adap_DocumentAndEntityInformationAbstract" xlink:to="dei_LocalPhoneNumber_638512202435375138" order="13" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications_638512202435375138" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adap_DocumentAndEntityInformationAbstract" xlink:to="dei_WrittenCommunications_638512202435375138" order="14" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial_638512202435375138" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adap_DocumentAndEntityInformationAbstract" xlink:to="dei_SolicitingMaterial_638512202435375138" order="15" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer_638512202435375138" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adap_DocumentAndEntityInformationAbstract" xlink:to="dei_PreCommencementTenderOffer_638512202435375138" order="16" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer_638512202435375138" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adap_DocumentAndEntityInformationAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer_638512202435375138" order="17" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle_638512202435375138" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adap_DocumentAndEntityInformationAbstract" xlink:to="dei_Security12bTitle_638512202435375138" order="18" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol_638512202435375138" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adap_DocumentAndEntityInformationAbstract" xlink:to="dei_TradingSymbol_638512202435375138" order="19" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName_638512202435375138" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adap_DocumentAndEntityInformationAbstract" xlink:to="dei_SecurityExchangeName_638512202435375138" order="20" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany_638512202435385135" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adap_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityEmergingGrowthCompany_638512202435385135" order="21" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey_638512202435385135" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adap_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityCentralIndexKey_638512202435385135" order="22" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag_638512202435385135" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="adap_DocumentAndEntityInformationAbstract" xlink:to="dei_AmendmentFlag_638512202435385135" order="23" use="optional" />
  </presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140437860393760">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>May 14, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_adap_DocumentAndEntityInformationAbstract', window );"><strong>Document and Entity Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May 14,  2024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-37368<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ADAPTIMMUNE THERAPEUTICS PLC<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">X0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">00-0000000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">60 Jubilee Avenue<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Adress Line Two</a></td>
<td class="text">Milton Park<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Abingdon, Oxfordshire<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">OX14 4RX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">GB<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">44<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">1235 430000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">American Depositary Shares, each representing 6 Ordinary Shares, par value &#163;0.001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ADAP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001621227<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_adap_DocumentAndEntityInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">adap_DocumentAndEntityInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>adap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( -LYKU@'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    " #;.:]8<RY:(N\    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+/
M3L,P#(=?!>7>NNE6#E&7"XC3)B$Q"<0M2KPMHOFCQ*C=V].6K1."!^ 8^Y?/
MGR6W.@H=$CZG$#&1Q7PWN,YGH>.&G8BB ,CZA$[E<DSXL7D(R2D:G^D(4>D/
M=42HJ^H>')(RBA1,P"(N1"9;HX5.J"BD"][H!1\_4S?#C ;LT*&G#+SDP.0T
M,9Z'KH4;8((1)I>_"V@6XES]$SMW@%V20[9+JN_[LE_-N7$'#F^[[<N\;F%]
M)N4UCK^R%72.N&'7R:^KA\?]$Y-U5:^+JBEXL^=<\+5HZO?)]8??3=@%8P_V
M'QM?!64+O^Y"?@%02P,$%     @ VSFO6)E<G",0!@  G"<  !,   !X;"]T
M:&5M92]T:&5M93$N>&UL[5I;<]HX%'[OK]!X9_9M"\8V@;:T$W-I=MNTF83M
M3A^%$5B-;'EDD81_OT<V$,N6#>V23;J;/ 0LZ?O.14?GZ#AY\^XN8NB&B)3R
M>&#9+]O6N[<OWN!7,B0103 9IZ_PP JE3%ZU6FD PSA]R1,2P]R"BPA+>!3+
MUES@6QHO(];JM-O=5H1I;*$81V1@?5XL:$#05%%:;U\@M.4?,_@5RU2-9:,!
M$U=!)KF(M/+Y;,7\VMX^9<_I.ATR@6XP&U@@?\YOI^1.6HCA5,+$P&IG/U9K
MQ]'22(""R7V4!;I)]J/3%0@R#3LZG5C.=GSVQ.V?C,K:=#1M&N#C\7@XMLO2
MBW <!.!1NY["G?1LOZ1!";2C:=!DV/;:KI&FJHU33]/W?=_KFVB<"HU;3]-K
M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
M.7\N?<^E[[GT/:'2MS<C?6?!TXM;WD9N6\3[KC':US0N*&-7<LW(QU2ODRG8
M.9_ [/UH/I[Q[?K9)(2OFEDM(Q:02X&S022X_(O*\"K$">AD6R4)RU3393>*
M$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.W<DOJMI2^M28X
M2O2QS'!.'LL,.V<\DAVV=Z =-?OV77;D(Z4P4Y=#N!I"O@-MNIW<.CB>F)&Y
M"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(\J(A[J&&F,_#
M0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R4E5@,5O& RN0
MHGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>9;'!51W/55OR
ML+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4XOT4SMA*7&+SC
MYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5YYN<KGHB=OJ7
M=\%@\OUPR4</Y3OG7_1=0ZY^]MWC^FZ3.TA,G'G%$0%T10(CE1P&%A<RY%#N
MDI &$P'-E,E$\ *"9*8<@)CZ"[WR#+DI%<ZM/CE_12R#ADY>TB42%(JP# 4A
M%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+A=OB5,V[&KXF
M8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.'<YMZN,)%K/]8UA[Y,M\Y<-LZW@->
MYA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> ,?-2K6J5D*Q$_
M2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:,]6+K#F-"F]!
MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M7>EYIK=WDWM)J'7N0;#W\!J-'<V/'[?\ 5!+ P04    " #;.:]8)!Z;HJT
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M2P$"% ,4    " #;.:]8!T%-8H$   "Q    $               @ $
M9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( -LYKUAS+EHB[P   "L"   1
M              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    (
M -LYKUB97)PC$ 8  )PG   3              "  <T!  !X;"]T:&5M92]T
M:&5M93$N>&UL4$L! A0#%     @ VSFO6-J43?22!   E!$  !@
M     ("!#@@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    (
M -LYKUB?H!OPL0(  .(,   -              "  =8,  !X;"]S='EL97,N
M>&UL4$L! A0#%     @ VSFO6)>*NQS     $P(   L              ( !
ML@\  %]R96QS+RYR96QS4$L! A0#%     @ VSFO6!PX9>H_ 0  / (   \
M             ( !FQ   'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( -LY
MKU@D'INBK0   /@!   :              "  0<2  !X;"]?<F5L<R]W;W)K
M8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( -LYKUAED'F2&0$  ,\#   3
M          "  >P2  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D
*/@(  #84      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.1.1.u2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="adap-20240514x8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00090 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.adaptimmune.com/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>adap-20240514.xsd</File>
    <File>adap-20240514_lab.xml</File>
    <File>adap-20240514_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" original="adap-20240514x8k.htm">adap-20240514x8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "adap-20240514x8k.htm": {
   "nsprefix": "adap",
   "nsuri": "http://www.adaptimmune.com/20240514",
   "dts": {
    "schema": {
     "local": [
      "adap-20240514.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "adap-20240514_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "adap-20240514_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "adap-20240514x8k.htm"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2023": 3
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 24,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 23
   },
   "report": {
    "R1": {
     "role": "http://www.adaptimmune.com/role/DocumentDocumentAndEntityInformation",
     "longName": "00090 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "Duration_5_14_2024_To_5_14_2024_0KCULC8OSkCsdxvrliLgvw",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "adap-20240514x8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_5_14_2024_To_5_14_2024_0KCULC8OSkCsdxvrliLgvw",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "adap-20240514x8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.adaptimmune.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.adaptimmune.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "adap_DocumentAndEntityInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.adaptimmune.com/20240514",
     "localname": "DocumentAndEntityInformationAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Document and Entity Information [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.adaptimmune.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.adaptimmune.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.adaptimmune.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.adaptimmune.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Adress Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.adaptimmune.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://www.adaptimmune.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.adaptimmune.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.adaptimmune.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.adaptimmune.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.adaptimmune.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.adaptimmune.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.adaptimmune.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.adaptimmune.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.adaptimmune.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.adaptimmune.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.adaptimmune.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.adaptimmune.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.adaptimmune.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.adaptimmune.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.adaptimmune.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.adaptimmune.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001558370-24-008208-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001558370-24-008208-xbrl.zip
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M+%1K-Y!VFRA=NZ\C]\66_!EW_E;>^_8_4$L#!!0    ( -LYKUAK&J.HC@0
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M*:HW_P]4G3-0=:X75;&U%-7M!5&-Y>9G-J=;4@7JI_+*,%482R'U+PAI1KF
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M1_IGCJ[A(R])R:'A>M3(!U?1'E&'L"DS(DP<P<]@!EF0(_#(B= NDY_V".;
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M14DK2_PN['W#+6^;ZC9I[IT1K:@4H.##:)0UV$GOGU!NOM;SBO!K$=[Q'-N
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M >_\:"Q@RNU5E9/OW_0+9>A_-\.+4SJV9[B)&H*4<XCQCFA@TA_DH^/IU(&
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M(X(OV'6F9T]43 M3EAKP6\'Y)2I(%N]J3M4J.NB8V@Y?$97R$$M/$.G?,>L
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MV#3.$?G"Y<Y3XT=D8VLT *V;N;8!+0K/TD7<-?' A<3$UTJ?5-A$G/X5T%V
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M$DYWO[A@G>9_B"!V26#N_5SSK73_\QSB? JO5_U/>G3/ *EKQ!:#Q%= /CE
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M)GNM%N/A-&1'@W.V'N&CMWE.UWYZ=[Y1&@@&T")7VKI]_!9!_RXT05P295C
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M[4_]+F3MBY!;U;=JG[[U\L_[+#,%.-S39FGZ[Q2[+RGO_PU02P$"% ,4
M" #;.:]8740:9LP#   ^#0  $0              @ $     861A<"TR,#(T
M,#4Q-"YX<V102P$"% ,4    " #;.:]85\Z8PY4%  "S/@  %0
M    @ '[ P  861A<"TR,#(T,#4Q-%]L86(N>&UL4$L! A0#%     @ VSFO
M6&L:HZB.!   7BH  !4              ( !PPD  &%D87 M,C R-# U,31?
M<')E+GAM;%!+ 0(4 Q0    ( -LYKUBJ!"6-1!T  *BO   4
M  "  80.  !A9&%P+3(P,C0P-3$T>#AK+FAT;5!+ 0(4 Q0    ( -LYKU@=
M#C.,C0P  'DM   8              "  ?HK  !A9&%P+3(P,C0P-3$T>&5X
>.3ED,2YH=&U02P4&      4 !0!- 0  O3@

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>adap-20240514x8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="adap-20240514.xsd" xlink:type="simple"/>
    <context id="Duration_5_14_2024_To_5_14_2024_0KCULC8OSkCsdxvrliLgvw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001621227</identifier>
        </entity>
        <period>
            <startDate>2024-05-14</startDate>
            <endDate>2024-05-14</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="Duration_5_14_2024_To_5_14_2024_0KCULC8OSkCsdxvrliLgvw"
      id="Tc_UrMgHWF7dEiBJCRz71v1Yg_2_1">0001621227</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="Duration_5_14_2024_To_5_14_2024_0KCULC8OSkCsdxvrliLgvw"
      id="Tc_s-VMlvcn-EycMYk3kB_9pA_3_1">false</dei:AmendmentFlag>
    <dei:EntityTaxIdentificationNumber
      contextRef="Duration_5_14_2024_To_5_14_2024_0KCULC8OSkCsdxvrliLgvw"
      id="Hidden_EKI0DcY0HES7XHCvhSvvtw">00-0000000</dei:EntityTaxIdentificationNumber>
    <dei:DocumentType
      contextRef="Duration_5_14_2024_To_5_14_2024_0KCULC8OSkCsdxvrliLgvw"
      id="Narr_QdeSxPRds0-og9j83FRK1Q">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="Duration_5_14_2024_To_5_14_2024_0KCULC8OSkCsdxvrliLgvw"
      id="Narr_vRCwpj02oUiTj8h1tY8D_Q">2024-05-14</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="Duration_5_14_2024_To_5_14_2024_0KCULC8OSkCsdxvrliLgvw"
      id="Narr_SqtrH2LwU0eaYSr-TDJgow">ADAPTIMMUNE THERAPEUTICS PLC</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="Duration_5_14_2024_To_5_14_2024_0KCULC8OSkCsdxvrliLgvw"
      id="Tc_cjnQgqgmKkyNbI7EkLS63g_1_0">X0</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="Duration_5_14_2024_To_5_14_2024_0KCULC8OSkCsdxvrliLgvw"
      id="Tc_im9xCY5cokuv6CyIwq0JCQ_1_2">1-37368</dei:EntityFileNumber>
    <dei:EntityAddressAddressLine1
      contextRef="Duration_5_14_2024_To_5_14_2024_0KCULC8OSkCsdxvrliLgvw"
      id="Narr_KBMlrHInF06YUN9Ricl6DA">60 Jubilee Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="Duration_5_14_2024_To_5_14_2024_0KCULC8OSkCsdxvrliLgvw"
      id="Narr_kUodsGQwnEOhX8gF8LUQ9w">Milton Park</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="Duration_5_14_2024_To_5_14_2024_0KCULC8OSkCsdxvrliLgvw"
      id="Narr_UQcv0B1KMkS3HhQDcfmAJQ">Abingdon, Oxfordshire</dei:EntityAddressCityOrTown>
    <dei:EntityAddressPostalZipCode
      contextRef="Duration_5_14_2024_To_5_14_2024_0KCULC8OSkCsdxvrliLgvw"
      id="Narr_v5_txZ0MkU2VsIPxnVHNMQ">OX14 4RX</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCountry
      contextRef="Duration_5_14_2024_To_5_14_2024_0KCULC8OSkCsdxvrliLgvw"
      id="Narr_K0v1cooHmkum9pUjrLMS0g">GB</dei:EntityAddressCountry>
    <dei:CityAreaCode
      contextRef="Duration_5_14_2024_To_5_14_2024_0KCULC8OSkCsdxvrliLgvw"
      id="Narr_XqB9XwCDP0yEaSbv1u3c-A">44</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="Duration_5_14_2024_To_5_14_2024_0KCULC8OSkCsdxvrliLgvw"
      id="Narr_wNw4WR8VSEGVk0kQoawW3g">1235 430000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="Duration_5_14_2024_To_5_14_2024_0KCULC8OSkCsdxvrliLgvw"
      id="Narr_c77Z3AvnMkCHt4LK3q--cw">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="Duration_5_14_2024_To_5_14_2024_0KCULC8OSkCsdxvrliLgvw"
      id="Narr_2V5K3gQyQUO6V_SJI7FaXA">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="Duration_5_14_2024_To_5_14_2024_0KCULC8OSkCsdxvrliLgvw"
      id="Narr_v7GPUAcuQUmLqlVGI6VmTQ">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="Duration_5_14_2024_To_5_14_2024_0KCULC8OSkCsdxvrliLgvw"
      id="Narr_FA1vISvpMkmIDTLV1Ea_zw">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="Duration_5_14_2024_To_5_14_2024_0KCULC8OSkCsdxvrliLgvw"
      id="Tc_7RIWzbn42UCEfXHd20BVdg_1_0">American Depositary Shares, each representing 6 Ordinary Shares, par value &#xa3;0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="Duration_5_14_2024_To_5_14_2024_0KCULC8OSkCsdxvrliLgvw"
      id="Tc_laFnw_-ccEWGjyuznqrdUA_1_2">ADAP</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="Duration_5_14_2024_To_5_14_2024_0KCULC8OSkCsdxvrliLgvw"
      id="Tc_n_80PjYbV0mrjdtVQaviyQ_1_4">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="Duration_5_14_2024_To_5_14_2024_0KCULC8OSkCsdxvrliLgvw"
      id="Narr_Y5E6Hiuxuk21c0soopIzSA">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
